Estimated Cancer Prevalence by Cancer Site and Gender, New York State, 2020

Source: New York State Cancer Registry

Site of Cancer Diagnosed in Last 5 Years Ever Diagnosed
Males and Females Males Females Males and Females Males Females
All Invasive Malignant Tumors 400,900 194,900 206,000 1155500 530,300 625,200
Oral cavity and pharynx 10,000 6,700 3,200 25,600 16,400 9,100
Esophagus 2,100 1,600 500 4,000 2,900 1,100
Stomach 5,500 3,100 2,400 13,100 7,200 5,800
Colorectal 30,900 15,900 14,900 95,700 46,500 49,200
Liver / intrahepatic bile duct 4,400 3,100 1,300 8,100 5,700 2,500
Pancreas 5,200 2,600 2,600 8,200 4,000 4,200
Larynx 2,600 2,100 600 7,800 6,100 1,700
Lung and bronchus 31,400 13,700 17,700 54,700 23,500 31,200
Melanoma of the skin 18,300 10,300 8,000 57,000 29,200 27,700
Female breast     74,500     251,000
Cervix uteri     3,200     18,600
Corpus uterus and NOS     17,400     57,900
Ovary     4,800     17,200
Prostate   70,800     227,600  
Testis   2,800     16,000  
Urinary bladder (incl. in situ) 20,600 15,500 5,100 56,800 41,300 15,500
Kidney and renal pelvis 16,200 10,400 5,800 44,300 27,400 16,900
Brain and other central nervous system 3,400 1,800 1,500 13,100 6,800 6,300
Thyroid 19,400 5,000 14,400 70,000 16,100 53,900
Hodgkin lymphoma 2,800 1,500 1,300 16,100 8,200 7,800
Non-Hodgkin lymphomas 19,000 9,900 9,000 55,000 28,500 26,500
Myeloma 7,300 3,900 3,300 13,700 7,200 6,500
Leukemias 12,500 7,300 5,200 35,500 20,000 15,500

Notes

  • Estimated number of residents alive as of January 1, 2020, diagnosed with cancer within the last 5 years or anytime in the past, respectively.
  • Numbers are rounded to the nearest 100.
  • Refer to https://www.naaccr.org/wp-content/uploads/2020/01/CINA12-16.v5.sec1_.pdf for a detailed description of prevalence methodology.